dcsimg Application Proof
 
Lepu Biopharma Co., Ltd. - B
YOU SHOULD READ THE WARNING IN THE DOCUMENT.
 
WARNING
IMPORTANT
EXPECTED TIMETABLE
CONTENTS
SUMMARY
DEFINITIONS
GLOSSARY OF TECHNICAL TERMS
FORWARD-LOOKING STATEMENTS
RISK FACTORS
WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTION FROM COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE
INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED]
DIRECTORS AND PARTIES INVOLVED IN THE [REDACTED]
CORPORATE INFORMATION
INDUSTRY OVERVIEW
REGULATORY OVERVIEW
HISTORY, DEVELOPMENT AND CORPORATE STRUCTURE
BUSINESS
CONNECTED TRANSACTIONS
DIRECTORS, SUPERVISORS AND SENIOR MANAGEMENT
RELATIONSHIP WITH CONTROLLING SHAREHOLDER
SUBSTANTIAL SHAREHOLDERS
SHARE CAPITAL
FINANCIAL INFORMATION
FUTURE PLANS AND USE OF PROCEEDS
[REDACTED]
STRUCTURE OF THE [REDACTED]
HOW TO APPLY FOR [REDACTED]
APPENDIX I ACCOUNTANT'S REPORT
APPENDIX II UNAUDITED [REDACTED] FINANCIAL INFORMATION
APPENDIX III PROPERTY VALUATION REPORT
APPENDIX IV TAXATION AND FOREIGN EXCHANGE
APPENDIX V SUMMARY OF PRINCIPAL LEGAL AND REGULATORY PROVISIONS
APPENDIX VI SUMMARY OF THE ARTICLES OF ASSOCIATION
APPENDIX VII STATUTORY AND GENERAL INFORMATION
APPENDIX VIII DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES IN HONG KONG AND AVAILABLE FOR INSPECTION